RSSCollection: Life Science Companies
- Alan Kligerman Discusses Academic and Early Professional Background
- Alan Kligerman Discusses Challenges of Dealing With Government Regualtions
- Alan Kligerman Discusses Challenges With Prelief
- Alan Kligerman Discusses Creation of SugarLo Ice Cream Business
- Alan Kligerman Discusses Decision To Focus on Lactose Intolerance
- Alan Kligerman Discusses Discovery of Prelief, For Acid
- Alan Kligerman Discusses Evolution Of Lactaid Product
- Alan Kligerman Discusses Expansion Into Pills And Use of 800 Line
- Alan Kligerman Discusses Failure and Importance of Listening To Your Customers
- Alan Kligerman Discusses FDA Approval Process and Bringing Lactaid To Market
- Alan Kligerman Discusses How He Handled Regulations Regarding Sale of Milk In New York City
- Alan Kligerman Discusses Intellectual Property Surrounding Beano
- Alan Kligerman Discusses Marketing and Growth of SugarLo Ice Cream Business
- Alan Kligerman Discusses Opposition From Dairy Industry
- Alan Kligerman Discusses Using Enzyme In Milk Production Process
- Alan Kligerman Shares Passion For Working With Enzymes and Belief That His Product Was The Best
- Alan Kligerman Shares Personal Story From Sale of Lactaid To Johnson & Johnson
- Alan Kligerman Shares Thoughts on What Makes Someone Entrepreneurial
- Alan Kligerman States Best Ideas Happen When Your Mind Is Unstructured
- Alan Kligerman States Importance of Enjoying the Journey Despite the Risks
- Alan Kligerman States Importance of Getting a Product To Market Even If It Isn't Perfect
- Alan Kligerman States Importance of Knowing Yourself of What Type of Work Environment Suits You
- Alan Kligerman States Importance of Maintaining Your Integrity
- Alan Kligerman States It Is History That Writes The Verdict On What You Do
- Alan Kligerman States Reality That People Will Fight a New Idea
- Alan Kligerman States When You Are Ahead of the Curve, It Takes The Market A While to Catch Up
- Alan Kligerman States You Can Aim For The Top But It Is Critical To Enjoy The Journey
- Andy Kessler Discusses Changes In Technology And Accessibility For Consumers
- Andy Kessler Discusses Economics Of Preventing a Heart Attack
- Andy Kessler Discusses Economimcs of Early Detection
- Andy Kessler Discusses Healthcare Spending In The Future and Impact Of Technology On Physicians
- Andy Kessler Discusses Improvements In Scanning Technology
- Andy Kessler Discusses Professional Background
- Andy Kessler Shares Story From Visit With Physician
- Andy Kessler Shares Thoughts on Insurance Costs
- Andy Kessler Shares Thoughts on Reducing Costs By Using Technology To Assist With Detection and Decision Making
- Andy Kessler States Early Detection Will Eventually Outpace Chronic Care Revenue
- Andy Kessler States Healthcare Is A Monster Market
- Andy Kessler States Healthcare Is In Position That Technology Was 20 Years Ago
- Andy Kessler States One Role of Technology Is To Decrease People Needed To Do Jobs
- Andy Kessler States Reality That Healthcare Has No Price Tags
- Andy Kessler States Shift To Early Detection Will Lead To Increase In Cancer Rates Since More Will Be Found
- Antônio Francisco Ferreira Neto Discusses Company Divisions At Unigen
- Antônio Francisco Ferreira Neto Discusses Creation of Junior Company
- Antônio Francisco Ferreira Neto Discusses Decision To Walk Away From Academia And Start Unigen
- Antônio Francisco Ferreira Neto Discusses Desire To Make Biology-Related Field His Profession
- Antônio Francisco Ferreira Neto Discusses Financing Used For Unigen
- Antônio Francisco Ferreira Neto Discusses Founding and Growth of Unigen'
- Antônio Francisco Ferreira Neto Discusses How He Climbed The Learning Curve
- Antônio Francisco Ferreira Neto Discusses How Unigen Expanded Bird-Sexing Product To Retail Consumers
- Antônio Francisco Ferreira Neto Discusses Interest in Biology
- Antônio Francisco Ferreira Neto Discusses Unigen's Plans For The Future
- Antônio Francisco Ferreira Neto Discusses Various Personal Roles At Unigen
- Antônio Francisco Ferreira Neto Provides Company Background on Unigen
- Antônio Francisco Ferreira Neto Provides Overview of Communion Economy Concept
- Antônio Francisco Ferreira Neto Shares Advice For Biologists Who Want To Work In Industry
- Antônio Francisco Ferreira Neto Shares Challenges of Running A Company In Brazil
- Antônio Francisco Ferreira Neto Shares His Philosophy On Difference Between Health and Biology
- Antônio Francisco Ferreira Neto Shares How Unigen's Website Improves Communication With Customers
- Antônio Francisco Ferreira Neto Shares Rewards He Has Found After taking The Risk of Being an Entrepreneur
- Antônio Francisco Ferreira Neto States His Role In Unigen Is Tied To The Business Side
- Antônio Francisco Ferreira Neto States Importance of Having Partners With Complementary Competencies and Similar Character
- Antônio Francisco Ferreira Neto States Unigen Didn't Plan In The Beginning But Now Relies On A Structured Planning Process
- Bruce Ganem Discusses Challenges That Scientists Face In Invention of Product Versus Execution of a Company
- Bruce Ganem Encourages Scientists To Join VC Firms
- Bruce Ganem Explains Scientists Must Work At Developing Personal Business Relationships
- Bruce Ganem Shares His Background
- Bruce Ganem States Importance of Developing a Curious Mind
- Bruce Ganem States Reality of Having Multiple Careers During Life
- Bruce Pratt Discusses History and Current Position of Genzyme
- Bruce Pratt Discusses Pre-Clinical Stage Opportunities
- Bruce Pratt Discusses Trends and Challenges if Healthcare Industry
- Bryan Pearce Discusses Alternative Sources of Funding For Biotech Startups
- Bryan Pearce Discusses Average Duration of VC Investment In Biotech Companies Before Exit
- Bryan Pearce Discusses Changes in VC Firm Activity From 2000 To 2005
- Bryan Pearce Discusses Follow-On Financing in 2004
- Bryan Pearce Discusses IPO Exit Strategies Among Healthcare-Related Companies in 2004
- Bryan Pearce Discusses Profit From VC Investment in 2004
- Bryan Pearce Discusses Profit From VC Investment in Healthcare Ventures in 2004
- Bryan Pearce Discusses Reasons For Aligning With Partner
- Bryan Pearce Discusses Sources of Initial Funding For Biotech Startups
- Bryan Pearce Discusses Where New VC Money Is Going Within Biotech Sector
- Bryan Pearce Investigates Influence of Venture Capital on Biotech Industry in 2004
- Bryan Pearce Investigates VC Investment in the Healthcare Sector
- Bryan Pearce Outlines VC Exit Strategy For Biotech Firms In 2005
- Bryan Pearce Provides Introduction To Talk and Shares Thoughts on Why Academics Are Linked To Biotech Companies
- Bryan Pearce Provides Overview of VC Funding Environment Within Biotech Sector
- Bryan Pearce Shares Thoughts on Early Stage Funding Gap For Biotechnology Startups
- Bryan Pearce Shares Thoughts on How Much Money A Biotech Startup Should Raise
- Bryan Pearce Shares Thoughts on the Technology Transfer Process
- Bryan Pearce States M&A Activity Within Biotech Sector Has Increased
- Bryan Pearce States Pace of Company Closure Has Slowed in 2004
- Bryan Pearce States Reality Is That Biotech Startups Face a Rough Road In Terms of Financing
- Bryan Pearce States Universities Must Be Catalysts For Technology Transfer
- Carl Weissman Concludes Accelerator Corp Is A Solution To Biotech Startup Investing
- Carl Weissman Discusses Accelerator Corp's Model Of Early Stage Biotect Startup Investment
- Carl Weissman Discusses Challenges Of Legal Issues Surrounding Formation of Accelerator And Accelerator VC Deals
- Carl Weissman Discusses Challenges of Risk and Effort In Biotech Startup Process
- Carl Weissman Discusses Consolidation in Venture Capital Arena
- Carl Weissman Discusses Financial Structure of Accelerator Corp.
- Carl Weissman Discusses Investment in DLST Startup
- Carl Weissman Discusses Investment in Homestead Clinical and Allozyne Startups
- Carl Weissman Discusses Investment in Spaltudaq Startup
- Carl Weissman Discusses Investment in VieVax Startup
- Carl Weissman Discusses Range in Valuations and Milestons Among Accelerator Deals
- Carl Weissman Discusses Shift In VC Funding Of Biotechs To Later Stage of Company Growth and Clinical Development
- Carl Weissman Discusses Sources of Deal Flow For Accelerator Corp
- Carl Weissman Discusses The Process of Doing An Accelerator Corp Deal
- Carl Weissman Discusses Valuation Process Used At Accelerator Corp
- Carl Weissman Outlines What Makes A Strong Candidate For Accelerator Corp Investment
- Carl Weissman Shaes Thoughts on Investing In Alternative Drug Delivery Technologies
- Carl Weissman States Accelerator Corp Is Trying To Solve Biotechnology Startup Problem
- Carl Weissman States Accelerator Corp Will Form and Run Biotech Startup Once Invested
- Carlos Guimarães Discusses Academic and Professional Background and Early Interest In Business
- Carlos Guimarães Discusses Advantage of Pursuing Venture Capital As An Entrepreneur
- Carlos Guimarães Discusses Challenges Of Being A Young Company
- Carlos Guimarães Discusses Culture Shock of Visiting Middle East For The First Time
- Carlos Guimarães Discusses Decision To Leave Family Business and Become Corporate Executive
- Carlos Guimarães Discusses Founding of BIOCANCER
- Carlos Guimarães Discusses Hiring Practices In A Family Business
- Carlos Guimarães Discusses How Participants Are Recruited For Clinical Trials
- Carlos Guimarães Discusses Personal Goals For Future
- Carlos Guimarães Discusses Specific Challenges That Have Faced BIOCANCER
- Carlos Guimarães Discusses What BIOCANCER Looks For When It Hires People
- Carlos Guimarães Feels Starting a Business In Brazil Is More Challenging Than Other Countries
- Carlos Guimarães Provides Overview of Company, BIOCANCER
- Carlos Guimarães Shares Thoughts on Challenges of Family Businesses
- Carlos Guimarães Shares Thoughts on Finding a Balance Between Work and Personal Life
- Carlos Guimarães States BIOCANCER Works With Both Public and Private Hospitals
- Carlos Guimarães States Brazilian Law Prohibits Clinical Trial Participants From Being Paid
- Carlos Guimarães States Businesspeople Learn Something Every Day
- Carlos Guimarães States Clinical Trials Must Be Run Efficiently
- Carlos Guimarães States Company Homepage In In English and Decision Was Made To Position Company As Global Competitor
- Carlos Guimarães States Entrepreneurs Must Be Willing To Overcome Problems
- Carlos Guimarães States Facing What Seems To Be Impossible Is A Huge Motivator
- Carlos Guimarães States Importance of Following Strong Clinical Research Protocols To Compete In Global Pharma Industry
- Carlos Guimarães States Importance of Initial Business Plan - Even If It Will Not Be Completely Followed
- Carlos Guimarães States Lack of Credibility and Lack of Funds Face Most Startups
- Carlos Guimarães States Partnership Must Have Solid Foundations That Are Maintained Daily
- Charles McClure Discusses Accountability and Learning From Mistakes
- Charles McClure Discusses Background of Company, ArvinMeritor
- Charles McClure Discusses Concept of Being Fast To Fail
- Charles McClure Discusses Importance In Getting Overseas Professional Experience
- Charles McClure Discusses Importance of Business Principles, Technology and Global Marketplace
- Charles McClure Discusses Influence of Engineering Degree On Method Of Leadership
- Charles McClure Shares Personal and Professional Background
- Charles McClure Shares Thoughts on Commercialized Innovation
- Charles McClure Shares Thoughts on Leadership and Technical Background of Those Leaders
- Charles McClure Shares Thoughts On The Global Economy
- Charles McClure States Engineering Is An Investment - Not a Cost
- Christoph Hergersberg Discusses 'So What?' Aspect To Personalized Medicine
- Christoph Hergersberg Discusses Aspects of Monitoring
- Christoph Hergersberg Discusses Challenge of Getting Customer Feedback
- Christoph Hergersberg Discusses Challenge of Making Medicine More Cost Efficient
- Christoph Hergersberg Discusses Decision Making Aspect of Personalized Medicine
- Christoph Hergersberg Discusses Difficulty Of Making Decisions When It Comes To Early Ideas and Innovations
- Christoph Hergersberg Discusses Gap Between New Technology and Market Adoption
- Christoph Hergersberg Discusses GE's Efforts With Technology Related To Health Care Integration
- Christoph Hergersberg Discusses Impact of Information Technology on Medicine
- Christoph Hergersberg Discusses Importance of Connecting With Customers
- Christoph Hergersberg Discusses Importance of Developing Drugs That Respond TO Niche Market Needs But Also Have Potential To Extend
- Christoph Hergersberg Discusses Importance of Improving Ending Processes In Pharm Industry
- Christoph Hergersberg Discusses Importance of Targeted Populations
- Christoph Hergersberg Discusses Pharma Product Life Cycle
- Christoph Hergersberg Discusses R&D Strategy Within Pharmas
- Christoph Hergersberg Discusses Relationship Between Big Pharmas and Small Biotech Companies
- Christoph Hergersberg Discusses Technology Management and Importance of Knowing Where You Want To Go
- Christoph Hergersberg Shares Thoughts on Biomarkers
- Christoph Hergersberg Shares Thoughts on Blockbuster Drugs
- Christoph Hergersberg Shares Thoughts on Drug Efficacy
- Christoph Hergersberg Shares Thoughts on Immunotherapy
- Christoph Hergersberg Shares Thoughts on R&D Growth Rates in Pharma Industry
- Christoph Hergersberg States Importance of Carefully Selecting The Problem
- Christoph Hergersberg States Importance of Looking At Problem By Going Back To Biology
- Christoph Hergersberg States Pharmas Are Realizing That Clinical Understanding Of Disease Is Central To R&D
- Christoph Hergersberg States Pharmas Try To Pick The Best Targets
- Christoph Hergersberg States Reality of Huge Knowledge Base Within Pharma Companies
- Colin Hill Discusses Accuracy Of GNS Technology
- Colin Hill Discusses Challenge Of Building Commercial Aspect To GNS
- Colin Hill Discusses Challenges of Insurance Reimbursement For GNS Services
- Colin Hill Discusses Educational Background and Decision To Found GNS
- Colin Hill Discusses Evolution From Pursuing Pharmaceutical Industry To Pursuing Cancer Patient Industry As Well
- Colin Hill Discusses GNS' Work With Cancer Treatment Center
- Colin Hill Discusses Human Genome Project And Impact of Bioinformatics
- Colin Hill Discusses Process of Cancer Drug Development
- Colin Hill Discusses Software Technology That GNS Uses To Simulate And Predict Drug Outcomes
- Colin Hill Outlines Background of Company, Gene Network Sciences (GNS)
- Colin Hill Outlines How GNS Makes Money
- Colin Hill States Challenge Of Running A Business When You Are A Scientist At Heart
- Colin Hill States Company Started With Very Limited Capital
- Colin Hill States Computer Models Increase Probability For Pharmaceutical Companies To Get New Drugs To Market
- Colin Hill States Developing A Cure And Making Money Need To Go Hand In Hand As Business Evolves
- Colin Hill States Ethical Issues Are At Center of Bioinformatics
- Colin Hill States GNS Is Working To Determine Drugs That Will Impact Cardiac Risk
- Colin Hill States GNS Technology Will Play Part In Curing Cancer
- Colin Hill States Poor Understanding Of Human Biology Leads To Medical Problems That GNS Is Trying To Solve
- Cristiane Ulbrich Discusses Academic Background
- Cristiane Ulbrich Discusses Advantages and Challenges of forming Partnerships When You Are A Small Business
- Cristiane Ulbrich Discusses Advantages of Quick Prototyping
- Cristiane Ulbrich Discusses Background of BCS Tecnologia
- Cristiane Ulbrich Discusses Calculating Initial Product Price of Valve
- Cristiane Ulbrich Discusses Challenge of Being a Small Business In Brazil
- Cristiane Ulbrich Discusses Challenges of Pursuing a Career In Mechanical Engineering
- Cristiane Ulbrich Discusses Challenges Of Working In A Family Business
- Cristiane Ulbrich Discusses Deciding To Pursue MBA Degree
- Cristiane Ulbrich Discusses Desire To See Product Leave The Idea Phase and Enter The Marketplace
- Cristiane Ulbrich Discusses First Professional Experiences
- Cristiane Ulbrich Discusses How Companies Function Within An Incubator
- Cristiane Ulbrich Discusses Importance in Believing In Your Dreams And Staying Motivated
- Cristiane Ulbrich Discusses Importance of Bridging Language Gap Between Medicine and Engineering
- Cristiane Ulbrich Discusses Importance of Product Planning Process
- Cristiane Ulbrich Discusses Importance of Understanding Certification Process In Other Countries
- Cristiane Ulbrich Discusses Incubator Support and Government Financing To Develop First Product
- Cristiane Ulbrich Discusses Motivation To Change Course In Professional Life
- Cristiane Ulbrich Discusses New Valve Product Developed By BCS Tecnologia
- Cristiane Ulbrich Discusses Patent Issues In Brazil
- Cristiane Ulbrich Discusses Project Submissions and Approvals
- Cristiane Ulbrich Discusses Using Incubator To Get Company Off The Ground
- Cristiane Ulbrich Shares Examples of Products Under Development That Use Quick Prototyping Techniques
- Cristiane Ulbrich Shares Thoughts For Women Who Want A Career In Mechanical Engineering
- Cristiane Ulbrich States Everyone Has Entrepreneurial Tendencies - But Entrepreneurs Are Willing To Make The Necessary Sacrifices
- Cristiane Ulbrich States Importance of Beginning Project With a Basic Outline And Then Fill In The Details
- Cristiane Ulbrich States Importance of Choosing Partners Carefully
- Cristiane Ulbrich States Product Development Process Took Longer Than Anticipated
- Cristiane Ulbrich States She Is An Entrepreneur Geared Towards The Market
- Dan Huttenlocher Explains There Are Rarely Clear Cut Answers in Business
- Dan Huttenlocher Shares His Background
- Dan Huttenlocher States Hot Topics Get Overfunded In VC Arena
- Dan Huttenlocher States Importance of Learning Good Problem Solving Skills
- Dan Huttenlocher States Technical People Are Better At Understanding and Stating The Problem
- Dan Huttenlocher States Value of Technology Comes From Larger Business Context
- Dana Callow Discusses Challenges In Determining Market Size
- Dana Callow Discusses Investments Made By Millenia Partners
- Dana Callow Discusses Market Opportunities That Millenia Partners Looks For
- Dana Callow Discusses Millenia Partners Expected Returns on Investment
- Dana Callow Discusses Options For Fund's Exit Strategy
- Dana Callow Discusses Reality of Relationships With Venture Capitalists
- Dana Callow Discusses Use of Market Validation To Determine What Products and Ideas Will Have Future Growth
- Dana Callow Discusses Wishes For Investment Opportunities and VC Competition in Healthcare Sector
- Dana Callow Provides Background on Millenia Partners
- Dana Callow Provides Background on Millennia Partners
- Dana Callow Provides Introduction To His Lecture On Validating Your Idea
- Dana Callow Shares Example of Dynamics In A Marketplace
- Dana Callow Shares Examples of Specific Deals With Which Millenia Partners Has Been Involved
- Dana Callow Shares Thoughts on Deal Flow and Holding Periods
- Dana Callow Shares Thoughts on Finding a Network of Potential Funders
- Dana Callow Shares Thoughts on How To Find Investment Opportunities
- Dana Callow Shares Thoughts on Investing Opportunity in Healthcare Industry
- Dana Callow Shares Thoughts on Performing Due Diligence
- Dana Callow Shares Thoughts on Valuation
- Dana Callow Shares Thoughts on VC Investing In Healthcare Industry
- Dana Callow States Being Turned Down By A VC Doesn't Mean You Have A Bad Idea
- Dana Callow States Corporate Investors Are Becoming More Sophisticated
- Dana Callow States Markets Want To Be Efficient
- Dana Callow States Millenia Partners Believes In Building Businesses - Not Just Financing
- Dana Callow States Millenia Partners Looks To Support The CEO and Not Replace The CEO
- Dana Callow States Money Is Available For Healthcare Startups
- Dana Callow States Time To Build Compny Is Usually Three To Five Years
- Daniel Simpkins Defines Concept of A Design Win
- Daniel Simpkins Discusses Entrepreneurship, Engineering and Business
- Daniel Simpkins Discusses Financial History in Telecom Industry
- Daniel Simpkins Discusses Hiring Great Employees and Use of Behavioral Interviewing
- Daniel Simpkins Discusses How Goals Can Be Changed
- Daniel Simpkins Discusses Personal and Professional Background and Founding of Hillcrest Communications
- Daniel Simpkins Discusses Realities of VC Firms in Late 1990s
- Daniel Simpkins Shares Thoughts on Mentorship
- Daniel Simpkins States Bar For Funding Has Been Raised Over Past Several Years
- Daniel Simpkins States Importance of Creating Business Plan Before Committing Capital
- Daniel Simpkins States Importance of Creating Goals For Business
- Daniel Simpkins States Importance of Hiring Great People and Executing
- Daniel Simpkins States Importance of Thinking Of What Is Not Possible
- Daniel Simpkins States Importance of Watching Expenses and Not Letting Money Corrupt the Business
- Daniel Simpkins States Not To Fear Changing Company Direction
- Daniel Simpkins States Startups Need Three Things: A Great Idea, Core Competency and a Market Window
- Daniel Simpkins States Success Is More About Fixing Errors Than Having Wins
- Daniel Simpkins Summarizes His Choice of Business Fundamentals
- David Gottlieb Discusses Importance of Process of Planning
- David Gottlieb Discusses Importance of Reducing Risk In Transitioning Technology To A Commercial Enterprise
- David Gottlieb States Importance of Having a Business Plan Before Seeking Financing
- David Gottlieb States Importance of Remembering To Build The Company While Raising Capital
- David Gottlieb States Initial Public Offering May Not Be Too Far Off As A Financing Option
- David McElroy Discusses Academic Background and Decision to Come to the US
- David McElroy Discusses Advantage of Being Acquired by Bigger Parent Company
- David McElroy Discusses Advantages of Being Spun Off Rather than Keeping a Larger Parent
- David McElroy Discusses Challenge of Staying With an Acquired Company Based on His Personality Type
- David McElroy Discusses Excitement of Running a Company
- David McElroy Discusses Experience at DeKalb, an Agricultural Biotechnology Company
- David McElroy Discusses Genetic Technology and Misunderstandings in Europe
- David McElroy Discusses Intellectual Property Issues
- David McElroy Discusses Personal Background and Decision to Become an Entrepreneur
- David McElroy Discusses Personality Trait Differences Between Small and Large Companies
- David McElroy Discusses Professional Background
- David McElroy Discusses Professional Path After Receiving PhD
- David McElroy Discusses Reality of the Grind Behind Product Development
- David McElroy Discusses Restructuring the Business Prior to Spinoff
- David McElroy Discusses Satisfaction of Developing a Product That Changes the Environment
- David McElroy Discusses Transition From Science to Business Side
- David McElroy Discusses Transition to Business Role at Maxygen
- David McElroy Discusses Vision For His Company's Future
- David McElroy Outlines Ownership of Verdia
- David McElroy Shares Thoughts on Corporate Culture
- David McElroy Shares Thoughts on Managing and Motivating People
- David McElroy Shares Thoughts on Managing Relationships and Providing Incentives
- David McElroy Shares Thoughts On Professional Future After Verdia is Acquired
- David McElroy Shares Thoughts on Risk
- David McElroy Shares Thoughts on Science versus Business and the Importance of Finding a Company Willing to Take a Chance on You
- David McElroy Shares Thoughts on the Ag Biotechnology Sector
- David McElroy Shares Thoughts on What Science Professionals Should Know About Business
- David McElroy States Rejection is Part of Being an Entrepreneur
- David McElroy The Relationship Between a Business Unit and the Parent Company
- David Potter States Business Is More About Positive Differentiation Than Uniqueness
- David Potter States Businesses Should Create Value and Have Effective Business Models
- David Potter States Importance of Having Someone On Management Team Who Can Deal With Broad Perspectives
- David Potter States Importance of Planning Ahead For Finding Funding Sources
- David Sinclair Discusses Challenge of Being An Academic In the Business World and the Roles He Has Played Within His Company
- David Sinclair Shares Thoughts on Conflict Of Interest Between Academic Role and Business Role
- David Sinclair Shares Thoughts on Time Requirements of Being a Scientist and Entrepreneur
- David Walt Discusses Challenges In Founding Life Sciences Company
- David Walt Shares Background of Illumina - Growing From Science To Business
- David Weinstein Discovers Process of Discovering How Brain Tumors Can Be Turned Off
- David Weinstein Discusses Challenges of Financing Biotech Companies
- David Weinstein Discusses Decision To Leave Stable Academic Center And Start Company
- David Weinstein Discusses Guiding Princples For Running GliaMed
- David Weinstein Discusses Scientific Approach At GliaMed
- David Weinstein Provides Background on His Company, GliaMed
- David Weinstein Shares Thoughts on Conflict of University As Simultaneously Being Ivory Tower and Business
- David Weinstein States Business Model Focuses On Generating Revenue Stream To Fund Other Initiaitves
- David Weinstein States Challenge of Being A Scientist In the World of Business
- David Weinstein States Wound Care Drug Came From Failure From Other Clinical Experiment
- Debra Goldfarb and Dana Callow Share Thoughts on Convergence Within Biotech Industry
- Debra Goldfarb Discusses Life Sciences Focus Within IBM
- Debra Goldfarb Provides Overview of Session 2
- Dianne Russell Discusses Importance of Shopping Around For A VC Firm and Making Sure There Is Strong Chemistry
- Dianne Russell Discusses Position of Bank When Company Starts To Fail
- Dianne Russell Discusses Role of Banks In Funding Startups
- Dianne Russell States Tech Startups Are A Money Game of Risk and Reward
- Donald Gulbrandsen Discusses Advantage of Being An Early Mover In India
- Donald Gulbrandsen Discusses Background and Founding of Gulbrandsen Chemicals
- Donald Gulbrandsen Discusses Career Path Choices and Decision to Create Startup
- Donald Gulbrandsen Discusses Cash Flow and Financing Concerns
- Donald Gulbrandsen Discusses Challenge of Learning How To Delegate
- Donald Gulbrandsen Discusses Challenges Presented By Competitors
- Donald Gulbrandsen Discusses Challenges Stemming From Transition Into Supervisor Role of Small Startup
- Donald Gulbrandsen Discusses Competition in Chemical Industry and Waste Recycling
- Donald Gulbrandsen Discusses Customer Base of Gulbrandsen Chemicals
- Donald Gulbrandsen Discusses Decision to Create Startup Company Immediately After Graduation
- Donald Gulbrandsen Discusses Decision to Fund Business By Using Debt
- Donald Gulbrandsen Discusses Desire to Stay With Company Rather Than Cash Out
- Donald Gulbrandsen Discusses Evolution of Business Plan Writing As Company Grew
- Donald Gulbrandsen Discusses Expansion To India and Separation of Company To Two Business Units
- Donald Gulbrandsen Discusses Future of Indian Operations
- Donald Gulbrandsen Discusses Growth of Chemical Company Over 12 Year Period
- Donald Gulbrandsen Discusses Importance of Having Overall Understanding of How Business Operates
- Donald Gulbrandsen Discusses Importance of Team Building Experiences as Undergraduate as Preparation for Professional Life
- Donald Gulbrandsen Discusses Importance of Understanding People and Cultural Differences
- Donald Gulbrandsen Discusses Love of Learning
- Donald Gulbrandsen Discusses Migration into Role of Manager As Company Continued to Grow
- Donald Gulbrandsen Discusses Potential for International Growth
- Donald Gulbrandsen Discusses Sustainable Competitive Advantage for Gulbrandsen Chemical
- Donald Gulbrandsen Discusses Thoughts on Entrepreneurship
- Donald Gulbrandsen Outlines Early Days of Gulbrandsen Chemical Business
- Donald Gulbrandsen Shares Example of Creating a Market Niche By Taking Away Chemical By-Products From Customers
- Donald Gulbrandsen Shares Example Where Moment of Crisis Led To Competitive Advantage
- Donald Gulbrandsen Shares Experience Starting A Business Directly Out of College
- Donald Gulbrandsen Shares Personal Educational and Early Professional Background
- Donald Gulbrandsen Shares Thoughts on Being a Builder Rather Than Entrepreneur
- Donald Gulbrandsen Shares Thoughts on Dealing With Fear
- Donald Gulbrandsen Shares Thoughts on Difficulty of Execution Once Idea is In Place
- Donald Gulbrandsen Shares Thoughts on Long Range Planning and Predictions
- Donald Gulbrandsen Shares Thoughts on Risk of Creating a Startup
- Donald Gulbrandsen Shares Thoughts on Stress
- Donald Gulbrandsen Shares Thoughts on Team Dynamics
- Donald Gulbrandsen Shares Vision Behind Gulbrandsen Chemical
- Donald Gulbrandsen States Advantage of Being a Young Entrepreneur Is a Different Risk Profile
- Donald Gulbrandsen States Company Growth Began to Eliminate Low Cost Advantage
- Donald Gulbrandsen States Engineers Have Excellent Problem Solving Skills But Sometimes Get Lost In The Details
- Donald Gulbrandsen States Funding Came Initially From Family and Bank
- Donald Gulbrandsen States Good Planning and Having a Competitive Advantage Are Key To Business Success
- Donald Gulbrandsen States Great Leadership Moments Come When You Can Openly Discuss Failures
- Donald Gulbrandsen States Hazardous Waste Regulations Led To Opportunities In Chemical Business
- Donald Gulbrandsen States If You Never Delegate, You Can Never Move On To More Important Things
- Donald Gulbrandsen States Importance of Becoming Comfortable With the Emotionally Uncomfortable Aspects of Business
- Donald Gulbrandsen States Importance of Being Open-Minded So You Can React To Unknowns
- Donald Gulbrandsen States Importance of Developing Product That Customers Want
- Donald Gulbrandsen States Importance of Finding Management With Similar Motivation and Enthusiasm
- Donald Gulbrandsen States Importance of Formalizing Business Relationships
- Donald Gulbrandsen States Low Cost of Labor Was Advantage During Initial Startup Phase
- Donald Gulbrandsen States Mistakes Can Also Occur When You Don't Take Advantage Of New Opportunities
- Donald Gulbrandsen States Mortality Keeps Him Awake At Night
- Donald Gulbrandsen States Motivation Can Be Gained From Embracing Central Vision and Mission
- Donald Gulbrandsen States Opportunities Lie In Getting Rid Of Other People's Pain
- Donald Gulbrandsen States Personal Strength Lies in Ability to Problem Solve
- Donald Gulbrandsen States Relationships In Family Businesses Require Specific Consideration
- Donald Gulbrandsen States Watching People Make and Recover From Mistakes Is A Valuable Management Tool
- Donald Gulbrandsen States Your Strength Can Be Your Biggest Weakness
- Donald Gulbrandsen Stresses Importance of Strong Team Building
- Doug Kahn Discuses Professional Experience and Shares Thoughts On Being Involved With A Startup
- Doug Kahn Discusses Company Growth And Challenges From Being In Pharmaceutical Industry
- Doug Kahn Provides Demo of Product From Ahura Scientific
- Doug Kahn States Reality That There Will Be Setbacks
- Eduardo Soares Discusses Academic Background and Interest in Biology
- Eduardo Soares Discusses Best Approach To Discovery
- Eduardo Soares Discusses Brazil's Ranking Within Global Biotechnology Stage
- Eduardo Soares Discusses Brazilian Governmental Impact on Biotechnology
- Eduardo Soares Discusses Challenge of Having Brazil Being Seen As Innovator In Biotechnology Industry
- Eduardo Soares Discusses Conflicts Between Biominas and Universities
- Eduardo Soares Discusses Future For Biominas
- Eduardo Soares Discusses Impact of Brazil's Biodiversity
- Eduardo Soares Provides Background on Biominas
- Eduardo Soares Shares Background of Biobras
- Eduardo Soares Shares Thoughts On How Opportunities Are Identified
- Eduardo Soares States A Strong Product and An Entrepreneurial Researcher Are Key
- Eduardo Soares States Biominas Has High Success Rate As An Incubator
- Eduardo Soares States Biominas Strives To Attract Good Business On A Global Basis
- Eduardo Soares States Biotechnology Projects Are Generally Longer Term
- Eduardo Soares States Brazilian Pharma Industry Needs To Continue To Develop Reliability Of Information
- Eduardo Soares States Companies Must Listen To Market And Be Open To Partnerships
- Eduardo Soares States Company's Infrastructure Supports Biotechnology Companies
- Eduardo Soares States Importance of Focusing on Diseases That Face Developing Countries
- Eduardo Soares States Incubator Has Flexible Graduation Timeline
- Eduardo Soares States Project Must Be Feasible For Marketplace
- Eduardo Soares States Researchers Are Not Always Ready To Start A Business
- Eduardo Soares States Technology Transfer Process In Brazil Is Improving
- Edward Heslop Discusses AnAerobics' Strategy and Advantages To Customers
- Edward Heslop Discusses Contracts, Revenue Streams and R&D
- Edward Heslop Discusses Current Financial Position of His Company, AnAerobics
- Edward Heslop Discusses Investor Audience That AnAerobics Is Targeting and Type of Pitch He Will Make
- Edward Heslop Provides Background on Company, AnAerobics
- Edward Heslop Shares Competitive Advantage of AnAerobics
- Edward Heslop Shares Thoughts on Attire
- Edward Heslop States AnAerobics Plans For Future Growth and Outlines Needed Funding
- Frances Toneguzzo Discusses Evolution of Tech Transfer Offices
- Frances Toneguzzo Discusses Technical, Legal and Networking Resources Available Through Technology Transfer Offices
- Frances Toneguzzo States People Are Strongest Resource In Technology Transfer Offices
- Fred Keller Discusses Four Goals of Cascade Engineering
- Fred Keller Discusses How Cascade Engineering Builds Social Capital
- Fred Keller Discusses Impact of Oil Depletion
- Fred Keller Discusses Innovation, Quality and Leadership
- Fred Keller Discusses Sustainability Concepts and the New Industrial Revolution
- Fred Keller Discusses Work With Chrysler on Plastic Vehicle Construction
- Fred Keller Provides Background on Company, Cascade Engineering
- Fred Keller Shares Thoughts On a Sustainable Business
- Fred Keller Shares Thoughts on Manufacturing Trends
- Harold Craighead Discusses Cornell University's History In Nanotechnology and Nanfabrication
- Harold Craighead Discusses Electron Beam Lithography
- Harold Craighead Provides Comparison of Nanotechnology Today To Where Transistors Were 50 Years Ago
- Harold Craighead Provides Example of How Nanotechnology is Being Used
- Harold Craighead Provides Examples of Research in Mircofluidics
- Harold Craighead Provides Overview on Nanotechnology
- Harold Craighead Shares Thoughts on Application of Nanotechnology in Biotechnology
- Helen Lockhart Discusses Challenges Related To Having the Freedom To Operate
- Helen Lockhart Discusses Circumstances When Obtaining a Patent Does Not Make Sense
- Helen Lockhart Discusses Concept of Inventorship
- Helen Lockhart Discusses Patent Cooperation Treaty (PCT)
- Helen Lockhart Discusses Specific Challenges Facing Life Science Patents
- Helen Lockhart Discusses Timelines of Patent Process
- Helen Lockhart Provides Definition of Novelty Destroying Disclosure
- Helen Lockhart Provides Overview on Patents
- Helen Lockhart Shares Thoughts on Patent Portfolio Management
- Helen Lockhart States Patents Are A Bargain With The Government
- Helen Lockhart States Record Keeping Is Critical To Patent Process
- Helen Maslocka Discusses Importance of Timing of Technology
- Helen Maslocka Shares Background of MedCool, Inc.
- Helen Maslocka Shares Thoughts on Ego and Relationships With Investors, Board and Advisors
- Helen Maslocka States Team is Most Important Asset In Starting Company
- James Sigler Discusses Background of Company, Air Systems Technology
- James Sigler Shares Patent Process Anecdote
- James Sigler States Becoming A Public Company Increases Your Expenses
- James Sigler States Importance of Getting All Pieces of The Business To Fit Together Before You Run Out Of Cash
- Janice Bourque Discusses Background of Comerica Bank and What Banks Need To Understand To Support Healthcare Startups
- Janice Bourque Discusses Challenges of Selling Product To Potential Financers
- Janice Bourque Discusses Entrepreneurship Versus Intrapreneurship
- Janice Bourque Discusses How A Bank Can Participate In Various Stages of Company Growth
- Janice Bourque Discusses Impact of Clinical Trials In Moving Product Through Development Process
- Janice Bourque Discusses What A Young Company Should Look For In A Bank Relationship
- Janice Bourque Discusses What Banks Are Looking For In Startup Companies
- Janice Bourque Discusses What Banks Will Look At In Early Stage Of Company Startup
- Janice Bourque States Importance of Being Prepared For Technology To Morph and Change
- Janice Bourque States Importance Of Doing What You Are Passionate About
- Jason Springs Describes Product Offered By GeneWeave Biosciences
- Jason Springs Discusses Academic and Professional Background
- Jason Springs Discusses Challenges of Dealing With FDA and Ensuring That Supply Chain Has Enough Volume
- Jason Springs Discusses Company's Competitors
- Jason Springs Discusses Differences In Pursuing Entrepreneurial Career Path Versus Traditional Path
- Jason Springs Discusses Excitement Over Company's Core Technology
- Jason Springs Discusses Impact of Company's Product On Healthcare
- Jason Springs Discusses Impact Of Running A Business While Taking Courses As An MBA Student
- Jason Springs Discusses Importance of Going Through Business Planning Process
- Jason Springs Provides Overview of Company, GeneWeave Biosciences, LLC
- Jason Springs Shares Thoughts on Balancing Business, School and Personal Life
- Jason Springs States A Strong Business Plan Conveys The Value To The Customer
- Jason Springs States A Strong Business Plan Doesn?t Spend a Lot of Time Discussing Technology
- Jason Springs States A Strong Business Plan Outlines Preparation for Contingencies
- Jason Springs States Being An Entrepreneur Is All About Creating Something New and Transformative
- Jason Springs States Business Planning Is A Process
- Jason Springs States Company Is In Process of Raising Seed Capital
- Jason Springs States He Chose Cornell For Graduate Work Because of Collaborative Opportunities
- Jason Springs States If You Aren't Making Mistakes Then You Aren't Trying Hard Enough
- Jason Springs States Importance of Adapting To Change and Getting Enough Sleep
- Jason Springs States Importance of Being Close To Your Clients
- Jay Schwartz Discusses Role of Angel Investors and Background of Keiretsu Forum
- Jay Schwartz Shares Thoughts on Inventor Transitioning To Entrepreneur and Experience That Come From Being In the Trenches
- Jay Schwartz States At End Of Day Angels Should Invest In Best Team
- Jay Schwartz States Importance of Angels Investing In Companies They Understand
- Jay Schwartz States Management Team Should Have Different Backgrounds and Positive Personal Interactions
- Jay Schwartz States Reality That Many Inventors Fear Losing Control Of Their Knowledge
- Jay Schwartz States Shares Thoughts on Company Team and Role of Advisors
- Jim Seay Discusses Decision to Position Premier Rides At Technical Leading edge
- Jim Seay Discusses Educational and Professional Background
- Jim Seay Discusses Impact of September 11th And Factory Fire on Premier Rides
- Jim Seay Discusses Importance of Volunterring and Giving Back
- Jim Seay Provides Examples of Product Offering From Premier Rides
- Jim Seay Shares Thoughts on Importance of Having a Reputable Network
- Jim Seay Shares Thoughts on Mentoring
- Jim Seay States Importance of Understanding All Levels of Organization and Impact of Honesty
- Jim Seay States Leaders Need To Exude Positive Energy
- John Abele Discusses Pros and Cons of Being a Big Company
- John Abele Shares Philosophy On Problem Solving
- John Abele Shares Thoughts on Passionate Leaders
- John Abele Shares Thoughts on Technology Transfer Within Universities
- John Abele States Entrepreneurs Identify Needs That Aren't Being Met
- John Abele States Organizations Are Most Productive When There Is Great Communication
- John Abele States Organizations Should Perform Self-Tests
- John Brenner Defines SWAG
- John Brenner Describes How C-Tech Transfers An Invention Into A Company
- John Brenner Discusses Business Planning and Startup Companies Within The University Setting And Associated Conflicts of Interest
- John Brenner Discusses C-Tech's Current Customer Base
- John Brenner Discusses Competition For Patents and Syndication
- John Brenner Discusses Cornell's Position on Licensing, Patenting and Ownership
- John Brenner Discusses Costs Associated With A Startup
- John Brenner Discusses Creating Business Plan and Getting Initial Funding For Startup
- John Brenner Discusses Developing a Startup To Transfer Product To Large Established Company
- John Brenner Discusses Excitement In Turning Research Into A Startup Company
- John Brenner Discusses Leadership of Companies and Initial Investment
- John Brenner Discusses Licensing Strategy
- John Brenner Discusses Mission of C-Tech (Cornell Center for Technology Enterprise and Commercialization) To Assist In Technology Transfer
- John Brenner Discusses Options With Regards To Their Use At C-Tech
- John Brenner Discusses Ownership Disputes
- John Brenner Discusses Patent Portfolio of Cornell University
- John Brenner Discusses Ways In Which Cornell Disseminates Research
- John Brenner Provides History of Ezra Cornell's Inventions Which Led To Founding Of Cornell University
- John Brenner Shares Background on Bayh-Dole Act and Cornell Center for Technology Enterprise and Commercialization
- John Brenner Shares Example of Marketing a Biodetector
- John Brenner Shares Thoughts on Dot Coms and Importance of Strong Networks
- John Brenner Shares Thoughts on Valuation
- John Brenner States Faculty Research Can Turn Into Licensed Material Which Can Derive Revenue To Run The University
- John Brenner States Grants Often Provide Significant Funding To Support Research
- John Callister Discusses Intellectual Property Issues In Mechanical Engineering Field of Noise and Vibration Control
- John Callister Shares His Background
- John Callister Shares Thoughts on Developing An Exit Strategy Early In Startup
- John Callister Shares Thoughts on the Future of the Automobile
- John Callister States Importance of Understanding That Products Must Generate a Positive Cash Flow
- John Callister States Product Development is Rational But Market Behavior is Not
- John Santini Discusses Advantage of Passive Implantable Devices
- John Santini Discusses Advantage of Using Network To Find CEO
- John Santini Discusses Background of Company, MicroCHIPS
- John Santini Discusses Cash Flow and Spending
- John Santini Discusses Challenges In Handling Changes In Product-Related Technology
- John Santini Discusses How Company Found First CEO
- John Santini Discusses Making Decision To Be in Business Versus Academia
- John Santini Discusses MicroCHIPS Corporate Partnerships
- John Santini Discusses Personal Choices For Work-Life Balance
- John Santini Discusses Structure of Implantable Device For Drug Delivery
- John Santini Discusses Use of Sensors In Implantable Device
- John Santini Discusses VC Funding for MicroCHIPS
- John Santini Shares Personal Experience In Learning From CEO-Mentor
- John Santini Shares Reality That The Inventor May Not Be The Right Person To Lead The Company
- John Santini Shares Thoughts on Company's Good Fortune In Having Patient Investors
- John Santini States If You Have The Opportunity To Raise Capital, You Should
- John Santini States Importance of Hairing A Team of People To Fill In Management Weaknesses
- John Santini States Intellectual Property Is Essential
- John Santini States MicroCHIPS Focus is Drug Delivery and Biosensing
- John Santini States Upfront Communication Is Critical
- Kathleen Mullinix Discusses Background of Company WellGen
- Kathleen Mullinix Discusses Importance of Having A Financing Plan
- Kathleen Mullinix Discusses Rights and Payments In Life Science Companies That Spin Off Universities
- Kathleen Mullinix States Financing Presents Biggest Challenge
- Kathleen Mullinix States Importance of Finding Investors Who Share Your Vision
- Kathleen Mullinix States Pharmaceutical Businesses Generally Have Greater Risks Than Other Industries
- Kesh Narayanan Discusses Importance of Building a Strong Team In Order To Sell The Idea
- Kesh Narayanan Discusses NSF and the Tech Transfer Process
- Kesh Narayanan Discusses NSF's Small Business Innovation Research Program (SBIR)
- Kesh Narayanan Shares Professional Background
- Kesh Narayanan States A True Entrepreneur Will Be Passionate About An Idea But Also See Its Commercial Value
- Kesh Narayanan States Amazement At Wealth of Ideas That Come Into SBIR Process
- Kesh Narayanan States Importance Of Creating a Systematic Approach To Entrepreneurial Education
- Kesh Narayanan States NSF Views Commercial Potential As An Importance Part of Each Proposal
- Kevin Jarrell Discusses Background of Company, Modular Genetics
- Kevin Jarrell Discusses Company Collaboration With Monsanto
- Kevin Jarrell Discusses Generating Revenue As A Startup
- Kevin Jarrell Discusses How He Chose VC To Partner With
- Kevin Jarrell Discusses Process of Raising Money
- Kevin Jarrell Discusses Professional Background and Timeline For Business Formation
- Kevin Jarrell Discusses Taking The Leap From Academia To Business
- Kevin Jarrell Shares Current Status of Company, Modular Genetics
- Kevin Jarrell Shares Thoughts on Company's Future
- Kevin Jarrell States Company Has Success In Hitting Milestones
- Kevin Jarrell States Importance of Being Innovative
- Kevin Jarrell States Key To Company Success Was Team Experience In Biotech Industry
- Kevin Jarrell States Partner Activity and Fund Raising Activity Are Two Key Future Goals For Company
- Kevin McGovern Discusses Challenge of Converting Excitement To Reality
- Kevin McGovern Discusses Challenges of Distributing Water Filters and Social Marketing
- Kevin McGovern Discusses Challenges of Distribution and Finding Appropriate Partners
- Kevin McGovern Discusses How His Company Has Taken Technology With Zero Monetization And Brought It To The Marketplace
- Kevin McGovern Discusses Invovlement in Nanotechnology
- Kevin McGovern Discusses KX Industries Which Provides Water Filtration
- Kevin McGovern Discusses Purpose of KX Industries
- Kevin McGovern Provides Background of McGovern and Associates
- Kevin McGovern Provides Insight on Challenges Facing World Regarding Water Filtration and Consumption
- Kevin McGovern States Advances in Nanotechnology Are Happening Now
- Kevin McGovern States Importance of Consumer Feedback
- Kevin McGovern States Importance of Having A Cash Cow Product To Fund Visionary Products
- Lance Stewart Discusses Academic and Professional Background
- Lance Stewart Discusses Board of Directors for Emerald Biostructures
- Lance Stewart Discusses Challenge of Training Science Students To Have Business Focus
- Lance Stewart Discusses Challenges in Being Academic and Business Owner at Same Time
- Lance Stewart Discusses Challenges of Balancing Startup with Family
- Lance Stewart Discusses Challenges of Valuation Prior to Acquisition
- Lance Stewart Discusses Decision to Form Partnership For Startup
- Lance Stewart Discusses Decision to Pursue MBA
- Lance Stewart Discusses Decision to Start Business, Emerald Biostructures
- Lance Stewart Discusses Definition of Entrepreneurship
- Lance Stewart Discusses Frustration of Practicing Science in a Business Setting
- Lance Stewart Discusses Funding For Startup
- Lance Stewart Discusses How Emerald Biostructures Became an Acquisition Target
- Lance Stewart Discusses Informal Business Plan That Was Put Together For Startup
- Lance Stewart Discusses Personal Background and Early Interest in Business
- Lance Stewart Discusses Problems With Cash Flow
- Lance Stewart Discusses Relationships With Larger Companies and the Royalty Percentages That Could Be Negotiated
- Lance Stewart Discusses Research As An Asset
- Lance Stewart Discusses Royalties
- Lance Stewart Discusses Two Acquisitions of Emerald Biostructures
- Lance Stewart Discusses Vision Changes for Company Post-Acquisition
- Lance Stewart Discusses Visions For the Future of the Business
- Lance Stewart Discusses Why Second Acquisition By DeCode Was Pursued
- Lance Stewart Outlines Current Position Within New Organization
- Lance Stewart Provides Overview of Company, DecodeGenetics
- Lance Stewart Provides Overview of Structural Biology
- Lance Stewart Shares Examples of Conflict of Interest Situations
- Lance Stewart Shares How He Would Perform Technology Transfer Differently
- Lance Stewart Shares Ideas For Why Roadblocks Might Exist in Technology Transfer From University to Business
- Lance Stewart Shares Thoughts on Entrepreneurship and Risk
- Lance Stewart Shares Thoughts on Negotiating Valuation
- Lance Stewart Shares Thoughts on Technology Transfer and Raising Funding From Industry
- Lance Stewart States Beginning a Startup With a Partner Is Easier But Future Decision Making Can Be More Challenging
- Lance Stewart States Challenges in Managing People and Budgets Were Some of Biggest Surprises
- Lance Stewart States Feeling That All Graduate Science Students Should Take An Accounting Course
- Lance Stewart States Frustration From R&D Limitations Can Often Lead To Faster Results
- Lance Stewart States His Group Became Part of DecodeGenetics Through Acquisition
- Lance Stewart States Importance of Business Students Learning Basic Science and Intellectual Property Issues
- Lance Stewart States Importance of Outlining Profitability In Addition to Science Goals During Presentation
- Lance Stewart States Limitations in Funding Required More Resourcefulness
- Lance Stewart States Main Competitive Advantage Came From Being an Early Mover In Industry
- Lance Stewart States Networking Aspect of MBA Program Was Not As Important As He Had Expected
- Lance Stewart States Weaknesses in University Technology Transfer Offices
- Larry Meier Discusses Cost Constraints in Licensing
- Larry Meier Discusses Due Diligence and Maintenance With Regards To IP
- Larry Meier Discusses Importance Aspects of a Licensing Agreement
- Larry Meier Discusses Importance of Intellectual Propertt Ownership
- Larry Meier Discusses Licensing Strategy and the Right To License
- Larry Meier Discusses Moentary Consideration With Regards To Licensing
- Larry Meier Discusses Purpose of a Licensing Agreement
- Larry Meier Discusses Sub-licensing, Reservation of Rights and Temrination
- Larry Meier Discusses Trade Secrets
- Larry Meier States Importance of Doing Licensing Agreement Correctly The First Time and Not Waiting For the Perfect Deal
- Laurence Blumberg Discusses Background of Syntonix and Technology Transfer Process
- Laurence Blumberg Shares Thoughts on Angel Investing and Creation of Management Team
- Laurence Blumberg Shares Thoughts on Pitching To VC Firms and Private Equity Market
- Laurence Blumberg Shares Thoughts on Valuing Startup Companies
- Laurie Halloran Discusses Challegnes Of Facing Institutional Review Boards (IRB)
- Laurie Halloran Discusses Need To Decide If You Plan To Pursue U.S. or Global Markets
- Laurie Halloran Discusses Pipeline Of Clinical Process
- Laurie Halloran Discusses Pressure To Develop Clinical Products Quickly
- Laurie Halloran States Clinical Products Have To Be Scalable
- Laurie Halloran States Collection of Clinical Data Is Expensive and Risky
- Laurie Halloran States Importance of Developing a Business Plan
- Laurie Halloran States Importance of Having A Goal So You Won't Get Distracted During The Long Approval And Testing Process
- Laurie Halloran States Importance of Having Strength on Both Medical End and Business End of Process
- Laurie Halloran States Importance of Listening To FDA Hints
- Laurie Halloran States Importance of Phase One Trials
- Laurie Halloran States Importance of Starting Out With a Strong Business Concept
- Laurie Halloran States Importance of Understanding Regulatory Landmarks
- Laurie Halloran States In Clinical Product Development, There Is Never Only One Answer
- Laurie Halloran States Many Phase Three Clinical Trials Are Done Internationally
- Laurie Halloran States Physicians Need To Learn To Be Sponsors and Investigators When Entering Clinical Research
- Laurie Halloran States Professional Role Is Helping Turn Clinical Medicine Into Clinical Research
- Lee Henderson Discusses Challenge in Transitioning From Science Background to Business Environment
- Lee Henderson Discusses Challenges of Building a Drug Development Company In Ithaca, NY
- Lee Henderson Discusses Patent Due Diligence Process
- Lee Henderson Provides Overview on Company's Product Focus
- Lee Henderson Shares Thoughts on How To Build a Successful Life Sciences Company
- Mark Brandt Discusses Business Background Of Notiva
- Mark Brandt Discusses Challenges of Applying Technology To Retailers
- Mark Brandt Discusses Conversation Which Led To Entrance Into Nanotechnology Investing
- Mark Brandt Discusses Educational Background and Early Ventures Into Entrepreneurship
- Mark Brandt Discusses First Professional Experience With Cargill
- Mark Brandt Discusses Move From Cargill To Arthur Andersen To His Startup, Notiva
- Mark Brandt Discusses Need To Find Balance Between Disclosing and Protecting Business Ideas
- Mark Brandt Discusses Potential To Bring Electrcitiy to Developing Countries
- Mark Brandt Discusses The Creation of The Maple Fund To Invest In Nanotechnology
- Mark Brandt Discusses Volunteer Activies With Prisons and Juvenile Detention Homes
- Mark Brandt Provides Introduction To His Lecture
- Mark Brandt Shares Example of How To Focus Company and Scale Your Time
- Mark Brandt Shares Examples of How Seed Investment Rounds Work
- Mark Brandt Shares Thoughts on Corporate Espionage and Publicity
- Mark Brandt Shares Thoughts on Current Demographic Trends
- Mark Brandt Shares Thoughts on Energy Companies
- Mark Brandt States Importance of Being Open To Different Industries Within Business
- Mark Brandt States Importance of Building a Sustainable Business Model
- Matthew McCooe Discusses Decision To Link Faculty Members With Business Students To Assist With Business Plan Writing Process
- Matthew McCooe Discusses Handling Intellectual Property Licences With University-Based Startups
- Matthew McCooe Discusses How Technology Transfer Process Works
- Matthew McCooe Discusses Phases of Company Valuation And How Intellectual Property Is Rewarded
- Matthew McCooe Discusses Return on Investment For University Startups
- Matthew McCooe Discusses Role of Technology Transfer Within Universities
- Matthew McCooe Discusses Trend Among Universities To Finance Early Research Since VCs Are Becoming More Conservative
- Matthew McCooe States Many Universities Are Creating Seed Funds and Small VC Funds To Finance Early-Stage Research Projects
- Pamela Marrone Defines Adoption Curve
- Pamela Marrone Discusses Being a Female CEO in the Agribusiness Industry
- Pamela Marrone Discusses Challenges of Managing Growth
- Pamela Marrone Discusses Competition in Biopesticide Business
- Pamela Marrone Discusses Determination of Initial Customer Base and Product Development
- Pamela Marrone Discusses Drive to Start Business AgraQuest
- Pamela Marrone Discusses Experience Working at Large Corporation
- Pamela Marrone Discusses Financing For AgraQuest
- Pamela Marrone Discusses Intrapreneurship and Building Business Skills
- Pamela Marrone Discusses Research and Development (R&D)
- Pamela Marrone Discusses Success Factors at AgraQuest
- Pamela Marrone Shares Thoughts on Analysis and Risk
- Pamela Marrone Shares Thoughts on Cash Flow and Company Growth
- Pamela Marrone Shares Thoughts on Hiring Sales People
- Pamela Marrone Shares Thoughts on How AgraQuest Differentiates Itself From Competition
- Pamela Marrone Shares Thoughts on Leadership
- Pamela Marrone Shares Thoughts on the Work-Life Balance
- Pamela Marrone States Biggest Difference Between Entrepreneur and Intrapreneur is Ability to Raise Money
- Pamela Marrone States Business Plan Was Developed Prior to Starting AgraQuest
- Pamela Marrone States Entrepreneurial Activities Can Be Hampered in Big Companies Due to Politics
- Pamela Marrone States Hiring the Right People is One of the Biggest Challenges
- Pamela Marrone States Importance of Being a Leader in the Company and in the Community
- Pamela Marrone States Importance of Finding Good Management Team
- Pamela Marrone States Importance of Having Pipeline of Products
- Pamela Marrone States International Business Was Created to Help Balance Risk
- Pamela Marrone States Involvement in Community Helps Rejuvenate
- Pamela Marrone States Mission, Vision and Strategy Have Remained Constant While Timelines Have Changed
- Pamela Marrone States Personal Background Was Different Due to Business and Technical Experience
- Pamela Marrone States Stock Options and Social Mission Attracts Employees
- Patricia Granahan Discusses Importance of Attorney's Background
- Patricia Granahan Discusses Realistic Expectations That Inventor Should Have
- Patricia Granahan Shares Thoughts on What an Inventor Should Expect From University Technology Transfer
- Paul McManus Defines The Scientist-Founder Role
- Paul McManus Discusses Advantage Of Working With Service Providers At Early Stage of Company
- Paul McManus Discusses Advantages of Fully Formed Management Team
- Paul McManus Discusses Growth of Advisory Board As Company Grows
- Paul McManus Discusses Importance of Building Depth As Startup Grows
- Paul McManus Discusses Importance Of Business Development Process
- Paul McManus Discusses Importance of Managing Cash Flow and Growth of Startup
- Paul McManus Discusses Key Participants In Venture Team
- Paul McManus Discusses Pathway That Startups Follow and States People Are Most Important Part of Business Plan
- Paul McManus Discusses Reasons Why VCs Will Not Invest
- Paul McManus Discusses Returns Within VC Company And Why Failures Occur
- Paul McManus Discusses Tech Transfer Process
- Paul McManus Discusses The Getting-To-Velocity Phase of Business Development
- Paul McManus Discusses The Infinity-And-Beyond Phase of Business Development Where You Enter Marketplace
- Paul McManus Discusses Typs of Deals That Millenia Partners Pursues
- Paul McManus Outlines The Launch Phase of Starting A Business
- Paul McManus Outlines Three Business Development Models
- Paul McManus Provide Background of Millenia Partners
- Paul McManus Provides Comparison Between Science Team and Business Team
- Paul McManus Provides Introduction To Lecture and States Most Important Aspect Of An Entrepreneur Is Ability To Get Stuff Done
- Paul McManus Provides Summary of Lecture On Life Sciences Business Development and VC Funding Relationship
- Paul McManus Shares Background of Millenia Partners
- Paul McManus Shares Characteristics of Strong Entrepreneurs
- Paul McManus Shares Personality Traits Of Strong Entrepreneurs
- Paul McManus Shares Thoughts on Building The Organization Beyond The R&D Team
- Paul McManus Shares Thoughts On How To Build A Management Team At A Life Sciences Startup
- Paul McManus Shares Thoughts On How To Build A Scientific Advisory Board At A Life Sciences Startup
- Paul McManus Shares Thoughts On Measuing The Quality Of The Investors With Whom A Startup Partners
- Paul McManus Shares Thoughts on Role of Advisory Board
- Paul McManus States Advisory Board Members Should Play Integral Role and Not Just Be For Appearances
- Paul McManus States CEOs Are Usually Brought In After Money Is In Place
- Paul McManus States Entrepreneurs Are Decision Makers Who Stretch The Rules
- Paul McManus States Entrepreneurs Need More Patience When Requesting Funding
- Paul McManus States Entrepreneurs Need To Be Flexible and Learn To Close
- Paul McManus States Entrepreneurs Polarize People With Their Passion
- Paul McManus States Lack Of Strong Executives In Life Science Companies
- Paul McManus States Life Science Startups Should Be Cautious When Dealing With Advisors
- Paul McManus States Mentors Act Like Parents
- Paul McManus States One of Biggest Mistakes Is When CEO Doesn't Release Control Of Operating Issues
- Paul McManus States Strong Entrepreneurs Can Focus On One Thing By Being Adaptive In Resource Allocation
- Paul McManus States Three Risks Of Investing Are Technology, Market and Team
- Paul McManus States VC Will Try To Determine Risks and Evaluate How Founding Team Will Handle Them
- Paul McManus States VCs Don't Invest In A Nice Looking Business Plan Or A Great Idea - They Invest In People
- Paul McManus States Venture Investors Are Evidence Oriented
- Peter Staudhammer Discusses Academic Freedom Versus Commercialization
- Peter Staudhammer Discusses Alignment With Graduate Busienss School To Assist With Project Evaluations
- Peter Staudhammer Discusses Balance of Power In Projects
- Peter Staudhammer Discusses Challenges of Handling IP At Universities
- Peter Staudhammer Discusses Commitment of Tenured Individual Versus Entrepreneur
- Peter Staudhammer Discusses Current Projects At Alfred Mann Institute
- Peter Staudhammer Discusses Distribution Of Funds
- Peter Staudhammer Discusses Establishment of Alfred Mann Institute
- Peter Staudhammer Discusses Freedom To Publish
- Peter Staudhammer Discusses Importance of Entrepreneurial Mindset Within Institute
- Peter Staudhammer Discusses Mistakes With First Project On Intubation
- Peter Staudhammer Discusses Opposition To Commercialization Within Academic Campus
- Peter Staudhammer Discusses Planning Involved In Decision Whether or Not To Pursue a Project
- Peter Staudhammer Discusses Process of Project Reviews and Decision To Pursue Or Reject Projects
- Peter Staudhammer Discusses Project Focus and Pace
- Peter Staudhammer Discusses Project Selection Process
- Peter Staudhammer Discusses Relationship Between Alfred Mann Institute and USC
- Peter Staudhammer Discussses Guidelines For Creation of Future Institutes
- Peter Staudhammer Provides Background of Alfred Mann
- Peter Staudhammer Shares Thoughts on Exit Strategies
- Peter Staudhammer States Alfred Mann Institute Has Been Able To Make Positive Impact On People' Lives
- Peter Staudhammer States Alfred Mann Institute Insists On Controlling Intellectual Property
- Peter Staudhammer States Importance of Betting On People
- Peter Staudhammer States Importance of Having Inventor's Cooperation
- Peter Staudhammer States Institue Does Not Award Grants - They Are Part of A Directed Commercialization Process
- Peter Staudhammer States Part of His Job Is To Answer To Capital Providers
- Peter Staudhammer States Projects Have Friction And Are Not Autocratic
- Peter Staudhammer States Rejected Pro